790 related articles for article (PubMed ID: 33958223)
1. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
MacIntyre CR; Costantino V; Trent M
Vaccine; 2022 Apr; 40(17):2506-2513. PubMed ID: 33958223
[TBL] [Abstract][Full Text] [Related]
2. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
[TBL] [Abstract][Full Text] [Related]
3. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
[TBL] [Abstract][Full Text] [Related]
4. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
Milne GJ; Carrivick J; Whyatt D
BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
[TBL] [Abstract][Full Text] [Related]
5. Comparing the impact of vaccination strategies on the spread of COVID-19, including a novel household-targeted vaccination strategy.
Voigt A; Omholt S; Almaas E
PLoS One; 2022; 17(2):e0263155. PubMed ID: 35108311
[TBL] [Abstract][Full Text] [Related]
6. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study.
Jentsch PC; Anand M; Bauch CT
Lancet Infect Dis; 2021 Aug; 21(8):1097-1106. PubMed ID: 33811817
[TBL] [Abstract][Full Text] [Related]
7. Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.
Wang T; Li C; Li H; Li Z
BMJ Open; 2022 Jul; 12(7):e057281. PubMed ID: 35831042
[TBL] [Abstract][Full Text] [Related]
8. Modelling herd immunity requirements in Queensland: impact of vaccination effectiveness, hesitancy and variants of SARS-CoV-2.
Sanz-Leon P; Hamilton LHW; Raison SJ; Pan AJX; Stevenson NJ; Stuart RM; Abeysuriya RG; Kerr CC; Lambert SB; Roberts JA
Philos Trans A Math Phys Eng Sci; 2022 Oct; 380(2233):20210311. PubMed ID: 35965469
[TBL] [Abstract][Full Text] [Related]
9. Contact-adjusted Immunity Levels against SARS-CoV-2 in Korea and Prospects for Achieving Herd Immunity.
Chun JY; Jeong H; Kim Y
J Korean Med Sci; 2021 Oct; 36(38):e272. PubMed ID: 34609093
[TBL] [Abstract][Full Text] [Related]
10. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
[TBL] [Abstract][Full Text] [Related]
11. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
She J; Hou D; Chen C; Bi J; Song Y
Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
[TBL] [Abstract][Full Text] [Related]
12. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
[TBL] [Abstract][Full Text] [Related]
13. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
[TBL] [Abstract][Full Text] [Related]
14. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
15. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
[TBL] [Abstract][Full Text] [Related]
16. Vaccinating Children against COVID-19: Commentary and Mathematical Modeling.
Hawkes MT; Good MF
mBio; 2022 Feb; 13(1):e0378921. PubMed ID: 35040706
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
Beukenhorst AL; Koch CM; Hadjichrysanthou C; Alter G; de Wolf F; Anderson RM; Goudsmit J
Eur J Epidemiol; 2023 Mar; 38(3):237-242. PubMed ID: 36738380
[TBL] [Abstract][Full Text] [Related]
18. Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil.
Ferreira LS; de Almeida GB; Borges ME; Simon LM; Poloni S; Bagattini ÂM; da Rosa MQM; Diniz Filho JAF; Kuchenbecker RS; Camey SA; Kraenkel RA; Coutinho RM; Toscano CM
Vaccine; 2022 Nov; 40(46):6616-6624. PubMed ID: 36210250
[TBL] [Abstract][Full Text] [Related]
19. Can Africa achieve herd immunity?
Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
[TBL] [Abstract][Full Text] [Related]
20. Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study.
Diarra M; Kebir A; Talla C; Barry A; Faye J; Louati D; Opatowski L; Diop M; ; White LJ; Loucoubar C; Miled SB
BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35193893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
